Oslo, 23 May 2025: Reference is made to the stock exchange announcement by NEXT Biometrics Group ASA ("NEXT" or the "Company") on 9 May 2025 regarding the resolution by the Annual General to grant share options to board members.

The below primary insiders of the Company have now entered into share option allocation letter agreements setting out the terms and conditions for the following number of share options granted to them:

- Hans Henrik Klouman (Chairman) has been granted 1,000,000 share options in the Company, following which he holds in total 1,000,000 share options.

- Tove Giske (Director) has been granted 200,000 share options in the Company, following which she holds in total 200,000 share options.

- Roy Tselentis (Director) has been granted 200,000 share options in the Company, following which he holds in total 200,000 share options.

Moreover, the exercise period for Siri Gomnæs Børsum's (Director) 200,000 share options in the Company has been extended from 1 June 2025 to 30 July 2027. Siri Gomnæs Børsum holds in total 200,000 share options.

With regard to the 2025 option program for board members, in total 50% of the options will vest on 9 May 2026 and 50% of the options will vest on 9 May 2027. For board members, the date of expiry for all vested options is the date falling 60 months after the date of grant. Any options that are not exercised at, or prior to, that date will lapse. The vesting period for the options is conditional on the person being a member of the board of directors at the date of vesting, meaning that the options that have not vested will lapse without compensation to the holder if the board member ceases to be a member of the board. Options that have vested shall not lapse without compensation before the expiry period of the options. Vested options must be exercised within six months from the date of the end of the board member's term.

The exercise price of the share options shall be equal to the average volume weighted market price of the Company's shares over the last five trading days prior to the date of grant, being NOK 5.16 for the board members that have now been granted options.

After the above-mentioned allotment, if all conditions are met, the total number of issued share options in the Company is 11,410,079.

This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

NEXT Investor contact:
Ulf Ritsvall (CEO), ulf.ritsvall@nextbiometrics.com
Eirik Underthun (CFO), eirik.underthun@nextbiometrics.com

About NEXT Biometrics
NEXT provides advanced fingerprint sensor technology that delivers uncompromised security and accuracy for the best possible user experience in the payment and fintech, government ID, access control and office and notebook markets. The company’s patented NEXT Active Thermal ® principle allows the development of large, high-quality fingerprint sensors with superior security level. NEXT Biometrics Group ASA is headquartered in Oslo, with sales, support, and development operations in Seattle, Taipei, Tokyo, New Delhi and Shanghai.